| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.04 | 0.8 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |